Context Therapeutics
CNTX----
Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Context Therapeutics(CNTX) the EBIT is -14.97 M (-53.38%), Miss estimate;the EPS is -0.15 (-66.67%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBITMiss expectations
-0.01B53.38%
-0.01B1.73%
-0.01B51.65%
EPSMiss expectations
-0.1566.67%
-0.09222.47%
-0.057864.20%
Upcoming earnings report - Q3 FY2026
Available dateNov 5, 2026
Estimate Revenue$0
Estimate EBIT-$11.17 M
Estimate EPS-$0.1077
Revenue
ActualEstimateUnit: USD
Quarterly
EBIT
ActualEstimateUnit: USD
Quarterly
Net income
ActualEstimateUnit: USD
Quarterly
EPS
ActualEstimateUnit: USD
Quarterly